Shafique Virani, MD, on Jan. 10 was appointed director of newly established biopharmaceutical company TauC3 Biologics.
Three things to know:
1. TauC3 Biologics, based in London, is developing an immunotherapy to prevent or halt the spread of neurodegenerative diseases such as Alzheimer's.
2. Dr. Virani completed his neurosurgery residency at the University of Cambridge Teaching Hospitals in England and is currently based in the San Francisco Bay area.
3. He has 15 years of experience in the life sciences industry focusing on building portfolios of companies in neuroscience, rare diseases and precision oncology.